首页|ncRNA介导的EphB4上调与低级别胶质瘤不良预后及肿瘤免疫浸润的相关性

ncRNA介导的EphB4上调与低级别胶质瘤不良预后及肿瘤免疫浸润的相关性

扫码查看
目的 探讨促红细胞生成素生成人肝细胞受体B4(erythropoietin-producing human hepatocellular receptors B4,EphB4)在低级别胶质瘤(lower-grade glioma,LGG)组织中的表达、其上游靶点以及与患者预后及肿瘤免疫浸润的相关性,分析其作为治疗靶点的潜在作用.方法 首先应用癌症基因组图谱(The Cancer Genome Atlas,TCGA)数据库胶质瘤数据分析EphB4在胶质瘤与正常脑组织中的表达差异,并用基因表达谱交互分析(Gene Expression Profiling Interactive Analysis,GEPIA)数据库分析EphB4对不同癌症生存期的影响.用R语言和starBase数据库分析EphB4可能上游调节非编码RNA(non-coding RNA,ncRNA).用肿瘤免疫评估资源(Tumor Immune Estimation Resource,TIMER)数据库进行EphB4表达与肿瘤免疫细胞浸润、免疫细胞生物学标志物和免疫检查点相关性分析.结果 UBA6-AS1/hsa-miR-346轴是最有潜力影响LGG中EphB4表达的上游ncRNA相关通路.同时,EphB4水平与LGG肿瘤免疫细胞浸润、免疫细胞生物学标志物、免疫检查点表达均呈显著正相关.结论 ncRNA介导的EphB4上调与LGG的不良预后和肿瘤免疫浸润相关.
Correlation of ncRNA-mediated Up-regulation of EphB4 with Poor Prognosis and Tumor Immunoinfiltration in Low-grade Glioma
Objective To investigate the expression of erythropoietin-producing human hepatocellular receptors B4(EphB4)and its upstream targets as well as correlation with prognosis in low-grade glioma(LGG),for analyzing its potential role as a therapeutic tar-get.Methods Firstly analyzed the expression of EphB4 in glioma and normal brain tissue by The Cancer Genome Atlas(TCGA)data-base.Then,Gene Expression Profiling Interactive Analysis(GEPIA)database was used to analyze the effects of EphB4 on various cancer survival.The possible upstream regulatory non-coding RNA(ncRNA)of EphB4 were analyzed by R and starBase database.The correla-tion of EphB4 with tumor immune cell infiltration,biomarkers of immune cells and immune checkpoint expression were analyzed using the Tumor Immune Estimation Resource(TIMER)database.Results UBA6-AS1/hsa-miR-346 axis was the most potential upstream non-coding RNA(ncRNA)related pathway to influence expression of EphB4 in LGG.At the same time,the level of EphB4 was posi-tively correlated with the tumor immune cell infiltration,immune cell biomarkers and immune checkpoint in LGG.Conclusion NcRNA-mediated up-regulation of EphB4 is associated with poor prognosis and tumor immunoinfiltration in LGG.

Low-grade gliomaErythropoietin-producing human hepatocellular receptors B4Non-coding RNAImmunoinfil-trationPoor prognosis

吴铮、任志伟、高润石、孙轲、张国君

展开 >

100053 北京,首都医科大学宣武医院功能神经外科

100045 国家儿童医学中心、首都医科大学附属北京儿童医院功能神经外科

低级别胶质瘤 促红细胞生成素生成人肝细胞受体B4 非编码RNA 免疫浸润 不良预后

2024

医学研究杂志
中国医学科学院

医学研究杂志

CSTPCD
影响因子:0.702
ISSN:1673-548X
年,卷(期):2024.53(2)
  • 25